Takahashi A, Ogasawara K, Matsuki N, Fujinaga K, Nakaya T, Ikuta K, Auwanit W, Honda M, Fukui Y, Sasazuki T, Iwabuchi K, Onoé K
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
Vaccine. 1998 Oct;16(16):1537-43. doi: 10.1016/s0264-410x(98)00042-5.
Peptide vaccines against HIV-1 were prepared according to the cassette theory that we had proposed previously. An amino acid sequence of B subtype consensus of the HIV-1 V3 region was introduced into the MHC binding component with a supermotif for various MHC class II. The peptide vaccines induced T-cell responses in the DQ6 mice in which only DQ6 molecules were expressed as MHC class II. By contrast, an original V3 peptide including the consensus sequence was non-immunogenic in the DQ6 mice. Antibodies obtained from the DQ6 mice immunized with the peptide vaccines neutralized laboratory B subtype strains of HIV-1 in vitro. It may be anticipated that these peptide vaccines protect infection of HIV-1 in DQ6 positive individuals.
根据我们之前提出的盒式理论制备了抗HIV-1的肽疫苗。将HIV-1 V3区B亚型共有氨基酸序列引入具有各种MHC II类超基序的MHC结合成分中。这些肽疫苗在仅表达DQ6分子作为MHC II类分子的DQ6小鼠中诱导了T细胞反应。相比之下,包含共有序列的原始V3肽在DQ6小鼠中无免疫原性。用肽疫苗免疫的DQ6小鼠产生的抗体在体外可中和HIV-1的实验室B亚型毒株。可以预期这些肽疫苗能保护DQ6阳性个体免受HIV-1感染。